Rabbit Polyclonal Antibody to FRAT2
货号:
P31006
别名:
GSK-3-binding protein FRAT2, Frequently rearranged in advanced T-cell lymphomas 2, FRAT-2, FRAT2
应用:
WB,IHC,IF
反应种属:
Human
抗体类型:
Primary antibody
Swissprot:
O75474
规格:
目录价
在线咨询
Description |
---|
The protein encoded by this intronless gene belongs to the GSK-3-binding protein family. Studies show that this protein plays a role as a positive regulator of the WNT signaling pathway. It may be upregulated in tumor progression. |
Specification |
|
---|---|
Aliases | GSK-3-binding protein FRAT2, Frequently rearranged in advanced T-cell lymphomas 2, FRAT-2, FRAT2 |
Entrez GeneID | 23401 |
Swissprot | O75474 |
WB Predicted band size | 24.1kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human |
Immunogen | This FRAT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 203-230 amino acids from the C-terminal region of human FRAT2. |
Formulation | Purified antibody in PBS with 0.05% sodium azide. |
Application |
|
---|---|
WB | 1/1000 |
IHC | 1/100-1/500 |
IF | 1/10-1/50 |
Product Image
-
Western blot analysis of lysates from human placenta and heart tissue lysates (from left to right), using FRAT2 Antibody (C-term)(Cat. #P31006). P31006 was diluted at 1:1000 at each lane. A goat anti-rabbit IgG H&L(HRP) at 1:5000 dilution was used as the secondary antibody. Lysates at 35ug per lane.
-
Confocal immunofluorescent analysis of FRAT2 Antibody (C-term)(Cat#P31006) with ZR-75-1 cell followed by Alexa Fluor 488-conjugated goat anti-rabbit lgG (green). DAPI was used to stain the cell nuclear (blue).
-
FRAT2 Antibody (C-term) (Cat. #P31006)immunohistochemistry analysis in formalin fixed and paraffin embedded human bladder carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of FRAT2 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.